Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Oncologists Share Reasons for Cancer Drugs' High Cost, Recommend Solutions

March 16, 2015 11:18 am | News | Comments

Increasingly high prices for cancer drugs are affecting patient care in the U.S. and the American health care system overall, say the authors of a special article published online in the journal Mayo Clinic Proceedings. Read more...


Cidara Therapeutics Files for IPO

March 16, 2015 11:18 am | by Ryan Bushey, Associate Editor | News | Comments

The biotech firm based in San Diego is only two years old. Read more...


New Sign-Up Under Health Care Law Gets Lukewarm Reception

March 16, 2015 10:50 am | by Ricardo Alonso-Zaldivar, Associated Press Writer | News | Comments

Several million people hit with new federal fines for going without health insurance are getting a second chance to sign up, and that could ease the sting of rising penalties for being uninsured. Read more....


Amgen's Cholesterol-Lowering Repatha Shows Positive Data

March 16, 2015 10:19 am | News | Comments

Amgen announced new detailed data from the Phase 3 YUKAWA-2 study evaluating Repatha (evolocumab), a novel investigational cholesterol-lowering medication, in Japanese patients with high cardiovascular risk and high cholesterol.  Read more...


Studies Boost Hopes for New Class of Cholesterol Drugs

March 16, 2015 10:00 am | by Marilynn Marchione, AP Chief Medical Writer - Associated Press | News | Comments

New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. The government will decide this summer whether to allow two of these drugs on the market. Read more...


Valeant, Salix Agree on Amended Terms for Merger Agreement

March 16, 2015 8:40 am | News | Comments

Valeant and Salix Pharmaceuticals announce an amended agreement for its anticipated merger. Read more...


German Court Orders Vaccination Cynic to Pay for Virus Proof

March 16, 2015 8:35 am | by The Associated Press | News | Comments

A German court has ruled that a prominent anti-vaccination advocate must pay a doctor 100,000 euros ($105,720) in prize money he had promised to anyone who could prove measles is a virus. Read more...


Pfizer Reports Top-Line Results from Phase 4 Study Evaluating Fibromyalgia Capsules

March 16, 2015 8:33 am | News | Comments

The primary endpoint of the study was not achieved as there was not a statistically significant difference between pregabalin and placebo in mean pain score. Read more...


Antibody Therapy Dramatically Improves Psoriasis Symptoms

March 16, 2015 8:28 am | by Rockefeller University | News | Comments

Many patients suffering from psoriasis showed significant recovery during clinical trials. Read more...


Clinical Trial Review Finds No Increased Risk of Suicide in Patients Using Chantix

March 16, 2015 8:28 am | by University of Bristol | News | Comments

The findings showed no evidence of an increased risk of suicidal behavior. Read more...


Valeant Announces HSR Clearance for Salix Acquisition

March 16, 2015 8:27 am | News | Comments

Valeant expects to be in the position to close the transaction on April 1, 2015. Read more...


10 U.S. Charity Staff to Leave Sierra Leone Amid Ebola Scare

March 16, 2015 8:27 am | by Clarence Roy-Macaulay and Robbie Corey-Boulet, Associated Press | News | Comments

Ten health care workers with a Boston-based nonprofit organization responding to Sierra Leone's Ebola outbreak are to be evacuated to the United States. Read more...


Anti-Herpes Drug May Help Control HIV

March 13, 2015 1:56 pm | by Stephanie Guzowski, Editor | News | Comments

A drug that’s used to control herpes simplex virus 2 (HSV-2) could reduce levels of HIV in patients who do not have genital herpes, finds a National Institutes of Health (NIH) study. Read more...


Diabetes Drug Shown Not to Increase Heart Failure Risk

March 13, 2015 12:17 pm | by University of Connecticut | News | Comments

People with the most common form of diabetes can take the new drug Alogliptin without concern for an increased risk of heart failure or cardiovascular disease, according to research by a UConn cardiologist published in the British medical journal, The Lancet. Read more..


Antibiotics Found to Have Unexpected Effects on Mitochondria

March 13, 2015 12:03 pm | News | Comments

An EPFL study has shown that tetracycline-based antibiotics have an unexpected effect on the development of many organisms. In addition to pointing out the issue of soil pollution by these antibiotics, which are widely administrated to livestock, the scientists call upon colleagues to explore the consequences of using them in experiments that modulate gene expression. Read more...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.